Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella
Clinical trial NCT01069471 · COMPLETED
Trial details
- NCT number
- NCT01069471
- Sponsor
- GlycoVaxyn AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.